In our biological product research and production facility, we materialize vaccines and medicines for the treatment and prevention of infectious diseases and other health conditions that might affect our population. We are here to save lives!

Keeping in mind that the SARS-CoV-2 virus mutates frequently, and each time vaccines will be less effective, it is likely that the population will need to be vaccinated at certain intervals. This is why we are currently developing a SARS-CoV-2 vaccine, which is now in preclinical trial stage and which we expect will be ready in 2023, and will be a good booster vaccine option, facilitating the procurement and distribution processes for Colombia and other countries in the region.

Among the vaccines we will initially develop, we have: a universal Coronavirus vaccine, Dengue, Chikungunya, Yellow Fever, Influenza and Zika. This represents a critical step towards the purpose of guaranteeing health independence for Colombia and Latin America.

Initially, and thanks to the work we develop with different allies overseas, we will be able to import biologicals necessary for the population in our country and the region. Once we initiate our operation, we will carry out processes such as fill and finish (the filling of vials with the vaccine, and the process of bottling the medication for its distribution), research and development, production, commercialization and transfer of vaccines and biologicals technology.